# Auro Laboratories Ltd (AUROLAB)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹275.8
Day Change: -0.02%
52W High: ₹317
52W Low: ₹159
Market Cap: ₹167 Cr

## Valuation
P/E: 51.53
P/B: 3.83
EPS: ₹5.2
Book Value: ₹70.01
Dividend Yield: 0%

## Returns
1Y Return: 7.65%

## Profitability
ROE: 4.76%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: 0%
Profit Growth: 0%
EBITDA Margin: 0%
Operating Margin: 0%

## About
Auro Laboratories Ltd is a Drug Manufacturers - Specialty & Generic company listed on BSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Auro Laboratories Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Receipt Of 'Certification Of Substances Department' From European Directorate For The Quality Of Medicines & Healthcare ('EDQM')
- Announcement: Receipt Of 'Certificate Of GMP Compliance Of A Manufacturer' From Swissmedic Swiss Agency For Therapeutic Products.
- BSE Filing: Receipt Of 'Certification Of Substances Department' From European Directorate For The Quality Of Medicines & Healthcare ('EDQM')

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-19T07:00:21.898Z
Price History Updated: 2026-05-19T07:00:22.483Z
Latest Price History Date: 2026-05-19
Technicals Updated: 2026-05-19T07:00:22.483Z
Quant Updated: 2026-05-19T07:00:22.483Z
Sentiment Updated: 2026-05-19T07:00:22.483Z
Financials Status: current
Financials Updated: 2026-05-18T12:30:01.148Z
Financials Last Attempt: 2026-05-18T12:30:01.148Z
Financials Provider Tried: database
Latest P&L Period: FY 2025
Latest Balance Sheet Period: FY 2025
Latest Cash Flow Period: FY 2025

## P&L (Mar 2015)
Revenue: ₹33.74 Cr
Operating Profit: ₹2.79 Cr (OPM 8.27%)
Net Profit: ₹0.58 Cr
Tax: ₹0.58 Cr

## Annual P&L History
Mar 2015: Rev ₹33.74Cr | PAT ₹0.58Cr | OPM 8.27%
Mar 2016: Rev ₹32.65Cr | PAT ₹0.8Cr | OPM 9%
Mar 2017: Rev ₹27.91Cr | PAT ₹0.88Cr | OPM 10.03%

## Balance Sheet (Sep 2025)
Total Assets: ₹99.1 Cr
Total Liabilities: ₹99.1 Cr
Borrowings: ₹42.72 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

---
Source: rupiya.io/stocks/aurolab
Disclaimer: For research and education only. Not investment advice.